Evidence map›Paper›PMID 28624868›Full record

ArticleGeroScience2017

How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

Allison E Aiello, Yen-Ling Chiu, Daniela Frasca

Open access · bronzeAbstract read
In one paragraph

Article in GeroScience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Allison E AielloDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Yen-Ling ChiuDepartment of Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
Daniela FrascaDepartment of Microbiology and Immunology, University of Miami Miller School of Medicine, Room #3146A, P.O. Box 016960 (R-138), Miami, FL, 33101, USA. dfrasca@med.miami.edu.
Far Eastern Memorial Hospital · TWUniversity of Miami · USUniversity of North Carolina at Chapel Hill · US

Funding

Social-biological predictors of heterogeneity in CVD risk in African AmericansP60MD002249 · NIMHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DIEZ ROUX, ANA VICTORIA · 2007 to 2016
$15.0M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Ecologic Stressors, PTSD, and Drug Use in DetroitR01DA022720 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI AIELLO, ALLISON E · 2007 to 2011
$4.7M
Life Course Socioeconomics, Acculturation, & Type-2 Diabetes Risk Among LatinosR01DK087864 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AIELLO, ALLISON E · 2012 to 2015
$2.6M
Infectious Links Between Psychosocial Stress and AgingR01AG040115 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AIELLO, ALLISON E · 2012 to 2014
$1.7M
Regulation of primary and memory B cell vaccine responses in the elderlyR56AG032576 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BLOMBERG, BONNIE B., FRASCA, DANIELA · 2015 to 2015
$598k
Molecular mechanisms for TNF-mediated inhibition of B lymphocyte functionR21AI096446 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BLOMBERG, BONNIE B., FRASCA, DANIELA · 2012 to 2013
$407k
NIAID NIH HHS R21 AI096446NIA NIH HHS R01 AG040115NIA NIH HHS R56 AG032576NICHD NIH HHS P2C HD050924NIDA NIH HHS R01 DA022720NIDDK NIH HHS R01 DK087864NIMHD NIH HHS P60 MD002249
6 · The paper itself

Abstract

Cytomegalovirus (CMV) is an important pathogen for both clinical and population settings. There is a growing body of research implicating CMV in multiple health outcomes across the life course. At the same time, there is mounting evidence that individuals living in poverty are more likely to be exposed to CMV and more likely to experience many of the chronic conditions for which CMV has been implicated. Further research on the causal role of CMV for health and well-being is needed. However, the strong evidence implicating CMV in type 2 diabetes, autoimmunity, cancer, cardiovascular disease, vaccination, and age-related alterations in immune function warrants clinical and public health action. This imperative is even higher among individuals living in socioeconomically disadvantaged settings and those exposed to high levels of chronic psychosocial stress.

Indexed as

AgingCytomegalovirus InfectionsCytomegalovirus VaccinesPovertyChronic DiseaseCongresses as TopicCytomegalovirusEvidence-Based MedicineHumansRisk FactorsUnited StatesVaccinationCytomegalovirus VaccinesAgingChronic diseaseCMVImmunitySocioeconomicVaccination

Identifiers

PMID28624868
PMCPMC5505887
OpenAlexW2626113915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.